Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2026-02-01 @ 3:29 AM
Study NCT ID:
NCT04480502
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2020-07-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
Sponsor:
Tracon Pharmaceuticals Inc.
Organization: